Najlaa Qassim Muftin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Najlaa Qassim Muftin has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Ghada Ben Salah
Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah 51452, Saudi Arabia
1 shared publication - Ghasaq Jabbar Kashtl
Mustansiriyah University
1 shared publication Huda A. Kareem Hussain
Department of Chemistry, College of Science, Mustansiriyah University, 10052 Baghdad, Iraq
1 shared publicationMahmoud Najim Al-Jibouri
Department of Chemistry, College of Science, Mustansiriyah University, 10052 Baghdad, Iraq
1 shared publication
Latest Publications
- Open Access
- 31 March 2026
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 39 (1) , 1-6
Estimation of 8-iso-PGF2α as a marker of oxidative stress in T2DM patients with and without dyslipidemia
Oxidative stress resulting from excessive production of reactive oxygen species (ROS) plays a pivotal role in the development of chronic diseases, including type 2 diabetes mellitus (T2DM) and its related metabolic disturbances. This study aimed to assess the biomarker 8-iso-prostaglandin-F2α (8-iso-PGF2α) as an indicator of oxidative stress in T2DM patients and to investigate its association with dyslipidemia, with the objective of determining its potential value in predicting early diabetesrelated complications. The study included 90 participants: 60 T2DM patients (30 with dyslipidemia and 30 without) and 30 age and sexmatched healthy controls. Fasting serum samples were analyzed for glucose and lipid profile using an autoanalyzer, while C-reactive protein (CRP) and 8-iso-PGF2α levels were measured using ELISA. Compared with healthy controls, patients with T2DM exhibited markedly elevated levels of oxidative stress and inflammatory markers, including significant increases in both 8-iso-PGF2α and CRP. Among individuals with T2DM, those with dyslipidemia showed substantially higher 8-iso-PGF2α concentrations and a slightly higher CRP levels compared with patients without dyslipidemia. Diagnostic assessment indicated that 8-iso-PGF2α showed moderate ability to distinguish T2DM patients with dyslipidemia from those without. These findings suggest that elevated 8-iso-PGF2α, particularly in dyslipidemic T2DM patients, may serve as a promising early marker for assessing the risk of T2DMassociated complications.
- 31 March 2026
- Published by Medical University of Lublin in Current Issues in Pharmacy and Medical Sciences
- Vol. 39 (1) , 1-6
Open AccessEstimation of 8-iso-PGF2α as a marker of oxidative stress in T2DM patients with and without dyslipidemia
Oxidative stress resulting from excessive production of reactive oxygen species (ROS) plays a pivotal role in the development of chronic diseases, including type 2 diabetes mellitus (T2DM) and its related metabolic disturbances. This study aimed to assess the biomarker 8-iso-prostaglandin-F2α (8-iso-PGF2α) as an indicator of oxidative stress in T2DM patients and to investigate its association with dyslipidemia, with the objective of determining its potential value in predicting early diabetesrelated complications. The study included 90 participants: 60 T2DM patients (30 with dyslipidemia and 30 without) and 30 age and sexmatched healthy controls. Fasting serum samples were analyzed for glucose and lipid profile using an autoanalyzer, while C-reactive protein (CRP) and 8-iso-PGF2α levels were measured using ELISA. Compared with healthy controls, patients with T2DM exhibited markedly elevated levels of oxidative stress and inflammatory markers, including significant increases in both 8-iso-PGF2α and CRP. Among individuals with T2DM, those with dyslipidemia showed substantially higher 8-iso-PGF2α concentrations and a slightly higher CRP levels compared with patients without dyslipidemia. Diagnostic assessment indicated that 8-iso-PGF2α showed moderate ability to distinguish T2DM patients with dyslipidemia from those without. These findings suggest that elevated 8-iso-PGF2α, particularly in dyslipidemic T2DM patients, may serve as a promising early marker for assessing the risk of T2DMassociated complications.
- Open Access
- 30 March 2023
- Published by Al-Mustansiriyah Journal of Science in Al-Mustansiriyah Journal of Science
- Vol. 34 (1) , 37-44
Study of the Arginase Activity and Other Biochemical Parameters in Patients with Coronary Artery Disease in Baghdad Governorate-Iraq
The most prevalent form of heart disease and the main cause of death in both developed and developing nations is CAD. It happens when "plaque," or cholesterol or other fatty deposits that accumulate on the inner wall of the artery, narrows or blocks the arteries that deliver blood to the heart. Over time, chest pain might develop as a result of the reduction in blood flow to the heart caused by this plaque accumulation. The study was designed to find if Arginase acts as a biomarker for diagnosing Coronary Artery Disease (CAD). A total of 90 individual samples were included in the present study, the control group consist of 40 healthy individual samples, while the CAD patients were 50 individual samples. Some biochemical parameters such as fasting blood glucose (FBG), troponin I(TnI), high sensitivity C-reactive protein (hs-CRP), lipid profile, lactate dehydrogenase (LDH), and Arginase activity were analyzed. The results of the current study showed no significant differences in the average age of patients (67.00±6.78) when compared with the control group (61.10±6.46), P>0.05. A significant increase Was found in the FBI level, cholesterol, triglycerides, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), TnI, hs-CRP, LDH, and Arginase activity in the patient's group when compared with the control group. While significant decrease (P<0.05) was revealed in the high-density lipoprotein (HDL) level in CAD patients in comparison to the control group. Also, there was a positive significant correlation between Arginase activity with each age and FBG. As for the ROC operator curve for Arginase, it was found that the area under the curve (AUC) was 0.953 with a sensitivity of 90%, and specificity of 95%. The results in the present study indicate a possible use of Arginase as a diagnostic marker for CAD.
- 30 March 2023
- Published by Al-Mustansiriyah Journal of Science in Al-Mustansiriyah Journal of Science
- Vol. 34 (1) , 37-44
Open AccessStudy of the Arginase Activity and Other Biochemical Parameters in Patients with Coronary Artery Disease in Baghdad Governorate-Iraq
The most prevalent form of heart disease and the main cause of death in both developed and developing nations is CAD. It happens when "plaque," or cholesterol or other fatty deposits that accumulate on the inner wall of the artery, narrows or blocks the arteries that deliver blood to the heart. Over time, chest pain might develop as a result of the reduction in blood flow to the heart caused by this plaque accumulation. The study was designed to find if Arginase acts as a biomarker for diagnosing Coronary Artery Disease (CAD). A total of 90 individual samples were included in the present study, the control group consist of 40 healthy individual samples, while the CAD patients were 50 individual samples. Some biochemical parameters such as fasting blood glucose (FBG), troponin I(TnI), high sensitivity C-reactive protein (hs-CRP), lipid profile, lactate dehydrogenase (LDH), and Arginase activity were analyzed. The results of the current study showed no significant differences in the average age of patients (67.00±6.78) when compared with the control group (61.10±6.46), P>0.05. A significant increase Was found in the FBI level, cholesterol, triglycerides, very low-density lipoprotein (VLDL), low-density lipoprotein (LDL), TnI, hs-CRP, LDH, and Arginase activity in the patient's group when compared with the control group. While significant decrease (P<0.05) was revealed in the high-density lipoprotein (HDL) level in CAD patients in comparison to the control group. Also, there was a positive significant correlation between Arginase activity with each age and FBG. As for the ROC operator curve for Arginase, it was found that the area under the curve (AUC) was 0.953 with a sensitivity of 90%, and specificity of 95%. The results in the present study indicate a possible use of Arginase as a diagnostic marker for CAD.